SCHEMBL8296283

SCHEMBL8296283

C[C@@H](NOC(=O)CC1OCCc2ccccc21)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
GAA P10253 1/20 0.47
THRB P10828 1/20 0.46
KMT2A Q03164 5/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
RAB9A P51151 3/20 0.45
KDM4E B2RXH2 3/20 0.45
TSHR P16473 2/20 0.45
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 4/20 0.44
XBP1 P17861 1/20 0.43
BLM P54132 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8296282 0.77 L3MBTL1 (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL7403424 0.76 MAPT (0.54) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL7396662 0.75 L3MBTL1 (0.63) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL20921292 0.75 L3MBTL1 (0.63) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL7399518 0.74 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL3563788 0.69 ALDH1A1 (0.74) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL9684696 0.68 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL9683619 0.68 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL9683704 0.68 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL13588569 0.68 MAPT (0.50) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed